Dr Lal PathLabs fell 5.23% to Rs 3683 on profit booking after soaring in the past four sessions.
The stock had advanced 13.79% in the past four trading sessions.In the past one month, the stock has fallen 9.90% as against 2.47% decline in the Sensex. It has surged 8.62% in the past one year compared with the Sensex's 31% rise.
On the technical front, the stock's RSI (relative strength index) stood at 58.025. The RSI oscillates between zero and 100. Traditionally, the RSI is considered overbought when above 70 and oversold when below 30.
The stock was trading above its 50-day, 100-day and 200-day simple moving average (SMA) placed at 3562.87, 3597.53 and 3578.67, respectively.
On a consolidated basis, Dr Lal Path Labs net profit jumped 10.56% to Rs 96.30 crore on 15.39% increase in revenue from operations to Rs 498.40 crore in Q2 September 2021 over Q2 September 2020.
Dr Lal PathLabs provides diagnostic healthcare services in India.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app